Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury.
Ontology highlight
ABSTRACT: The intestinal flora plays an important role in the development of many human and animal diseases. Microbiome association studies revealed the potential regulatory function of intestinal bacteria in many liver diseases, such as autoimmune hepatitis, viral hepatitis and alcoholic hepatitis. However, the key intestinal bacterial strains that affect pathological liver injury and the underlying functional mechanisms remain unclear. We found that the gut microbiota from gentamycin (Gen)-treated mice significantly alleviated concanavalin A (ConA)-induced liver injury compared to vancomycin (Van)-treated mice by inhibiting CD95 expression on the surface of hepatocytes and reducing CD95/CD95L-mediated hepatocyte apoptosis. Through the combination of microbiota sequencing and correlation analysis,
SUBMITTER: Wang H
PROVIDER: S-EPMC8820816 | biostudies-literature | 2022 Jan-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA